Brief: Pharnext Appoints Dr. Burkhard Blank As New CMO And Head Of R&D
22/11/2021 17:06
Nov 22 (Reuters) - PHARNEXT SA PHARN.PA :
* PHARNEXT APPOINTS DR. BURKHARD BLANK AS NEW CHIEF MEDICAL
OFFICER AND HEAD OF RESEARCH & DEVELOPMENT
* APPOINTMENT EFFECTIVE JANUARY 1, 2022
* DR. BLANK WILL CONTINUE TO PROVIDE PART-TIME CONSULTING
SERVICES
TO ACORDA IN 2022
Source text for Eikon: ID:nEQcd4Vtta
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development